Description: | 4-[2-(5-Bromo-quinoxalin-6-y(amino)-4,5-dihydro-diacetate-imidazol-1-yl] 4-Oxo-butyric Acid is an intermediate in the synthesis of Brimonidine L-Tartrate Lactam (B677545), an impurity of Brimonidine ( B677520). Brimonidine ( B677520) is an a2 receptor agonist, used to treat glaucoma. |
Molecular Weight: | 508.29 |
Molecular Formula: | C19H18BrN5O7 |
Solubility: | THF, DHF, DMSO |
References: | Katz, L.J., et al. Am. J. Ophthalmol., 127, 20 (1999); Cantor, L. B., Expert Opin. Pharmacother., 1, 815 (2000). |
Customer Support
If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?
Customer Centered
Related Functional Groups
Other Building Blocks
N-((4-Oxo-1-phenyl-4,7-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-yl)methyl)acetamide
Customers Also Viewed
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
Copyright © 2024 BOC Sciences. All rights reserved.
Our Products